Pharmalicensing.com Send to a colleague
May 2012 Innovaro Pharmalicensing Recommends...
 
Innovaro Pharmalicensing recommends...

Top 5 Recommendations

 
Novel anti-inflammatory compound with wound healing/anaesthetic properties suitable for a wide range of dermatological and dental applications
This unique therapeutic topical agent is capable of healing wounds/scars/burns and has many potential uses in the dermatological, dental and hospital/surgery market more

 
Seeking proprietary, ready-to-market, oncology/supportive and palliative care/haematology/pain products for commercialisation in Germany
With a strong sales network set up in Germany our clients are looking to bring in further niche oncology products that are close-to-market more
 
 
Novel and innovative animal health products sought for distribution and/or licensing into Russia
Our client is a firmly established Russian animal health company with a strong distribution network that seeks to in-license new animal health products for the Russian marketplace more   
 
 
‘Combiflex’ three-chamber parenteral nutritional lipid bag, ready to distribute in the USA, mainland Europe and Australia 
The three-chamber ‘Combiflex’ lipid bag provides a key source of glucose, amino acid solutions and fat emulsions to patients and children over the age of 2 who are unable to administer nutrition through the oral or enteral route more
 
 
 
Global Animal Health Company seeks new veterinary external anti-parasitic compounds to treat companion (dogs and cats) and food producing (pigs, cattle, chickens) animals
Our global animal health clients seek new anti-parasitic compounds to treat external parasites affecting companion animals (dogs, cats etc.) and food producing animals (e.g. pigs, cattle, chicken) more

 

Out-Licensing

Novel anti-inflammatory omega-3 fatty acids sourced from green lipped mussels 
The omega-3 fatty acids are extracted from New Zealand green lipped mussels and developed into oils for use in anti-inflammatory compounds by our UK based clients more
 
 
Adipose tissue derived stem cells available for development to treat musculoskeletal, metabolic, ophthalmic or cardiovascular related disorders 
Our client is looking for partners to further develop and commercialize stem cells, sourced from adipose tissue for the treatment of regenerative medicine and anti-ageing more
 
 
EU patent for the preparation of an injectable form of anti-ulcer drug Rabeprazole
Our clients have a patent available for acquisition or licensing for a novel preparation method of Rabeprazole in the EU and Turkey (excluding Portugal) more  
 
 
 
Small molecule platform capable of enhancing osteogenic differentiation of stem cells for the treatment of bone disorders
Scientists at the forefront of regenerative medicine based at the Biomatcell Vinn Excellence Center of Biomaterials have identified this small molecule platform with these unique osteogenic differentiating properties and are now looking to develop them more
 
 
Pure, safe, concentrated and effective Carbo-Hydrate Derived Fulvic Acid with broad applications in antimicrobial, antiviral and preservative markets, available for licensing/co-development 
The CHD-FA broad spectrum characteristics allow for several potential market applications and our clients are now seeking to explore these markets further with partners more
  
 
Anti-microbial Monocaprin emulsion, available for use as a cleaning solvent in the preparation and protection of food, detergents and cosmetics
Our client is an academic institution that has developed a unique anti-microbial monocaprin emulsion with key cleaning solvent properties indicated primarily for the preparation and protection of food and cosmetics more

 

Unique “Plant Milking” Technology capable of producing high value active cosmetic compounds from the roots of rare, protected, slow to grow plant species
The ‘green technology’ allows the extraction of cosmetically active compounds from plants using root exudation without harming the plants involved more

  

Herbal portfolio of natural medications and cosmetics available for licensing/divestment with some regulatory work needed for local markets
Our client has developed of a wide range of herbal medications indicated for the treatment of many diseases. The entire portfolio of products is now available for licensing/sale more
 
 
 
Astaxanthin-related small molecule pro-drugs indicated for inflammation-driven disorders including metabolic, arthritic, hepatic, cardiovascular, ocular, and prostate diseases
Our US based clients have developed a platform of Astaxanthin-related small molecule anti-inflammatory pro-drugs, including an orally delivered lead compound, and are now looking for co-development/licensing partners more
 
 
 
Unique dendritic cell based cancer vaccine platform technology available for the development of new products
Our UK based company has developed a cancer vaccine platform technology, utilising dendritic cells, and is now looking to identify companies who can use this technology to develop their own products more   
 

Omega-3 fatty acids to treat joint care, asthma and dermatitis in animals 
Our clients are sourcing and developing unique omega-3 fatty acids from green lipped mussels for the treatment of joints, asthma and dermatitis in animals more

 

Inside...
  • Discover more details about each of these opportunities by visiting our company profile page . Each listing is categorized by both therapy and industry sector.

 

In-licensing

Oncology or neurology Phase I/Phase II products and/or technologies sought for in-licensing or acquisition 
Our leading apoptosis focused clinical stage drug development company seeks to in-license or acquire early stage clinical projects or technologies at phase I or II in the areas of either oncology or neurology more
 
 
Seeking innovative oncology, immunology or orphan disease focused prescription based hospital products required for the Portuguese market 
Our Portuguese clients are seeking to in-license prescription based hospital products indicated for the treatment of oncology, immunology and orphan diseases more
 
  
 
Seeking partners in Nigerian, Kenyan and Angolan markets for distribution of prescription pharmaceuticals 
Long standing experienced South American Laboratory is seeking to expand its distribution of prescription products into Nigeria, Kenya and Angola more
 
 
Seeking very late stage and market ready prescription products or medical devices for the US market 
Our clients seek prescription products, medical devices and nutraceuticals focused in the following therapeutic areas: urology, pediatrics, ENT, dermatology, OBGYN, family medicine, obesity and rheumatoid arthritis more  
 
 
Well established UK company seeks finished prescription products to add to its portfolio (channel partnering, divestments, distribution)
Our UK based clients offer experience within the Neurology, Oncology, Haematology, and Ophthalmology markets, but are now seeking to expand their portfolio via channel partnering, distribution or acquiring divested products in any therapeutic area more  

 

For further detailed information on each of these opportunities, including who to contact, visit our company profile page

Each partnering opportunity includes the following information:

  • Contact details
  • Full opportunity description
  • Stage of development
  • Type of partnering relationship sought
 

Innovaro Europe Ltd
Marlborough House, Westminster Place
York Business Park, YO26 6RW
United Kingdom
Email:  info@pharmalicensing.com
Registered in England and Wales no 01394542

Innovaro Europe Ltd
If you no longer wish to receive this newsletter please unsubscribe